Araz Rawshani, Sahlgrenska Academy at the University of Gothenburg. Photo by Charlotta Sjöstedt
News | Sudden Cardiac Arrest
Cardiac Arrest Survival Rate Rising

September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...

Home September 09, 2022
Home
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip lock malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott.
News | Heart Valve Technology
FDA Alerts Healthcare Providers to Potential for Clip Lock Malfunctions in Abbott MitraClip Device

September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip ...

Home September 09, 2022
Home
investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital
News | Cardiovascular Clinical Studies
FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

Home September 08, 2022
Home
PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the intellectual property and technology assets of LindaCare, a digital health company specializing in remote monitoring.
News | Remote Monitoring
Leading Cardiac Remote Monitoring Company Acquires Technology IP to Boost Its Robust Product Portfolio

September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the ...

Home September 08, 2022
Home
The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias
News | Catheter
Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology

September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...

Home September 08, 2022
Home
Top 10 content for the month of August 2022
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: A Look at the Hot Topics from August

Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and ...

Home September 07, 2022
Home
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population
News | Cardiovascular Surgery
Volta Medical’s AI Based solution for Patients in Atrial Fibrillation Achieves Robust Validation in First Peer-Reviewed Publication

September 7, 2022 — Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...

Home September 07, 2022
Home
Graphical abstract During COVID19 total lockdown in 2020 in France, a significant reduction in vascular stiffness, recorded by home smart scales, was observed.© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society o f Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me
News | Coronavirus (COVID-19)
Strict COVID Lockdowns in France Improved Cardiovascular Health

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

Home September 07, 2022
Home
Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration
News | SPECT-CT
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

Home September 07, 2022
Home
Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022
News | Pharmaceuticals
Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...

Home September 06, 2022
Home
Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life
News | Pharmaceuticals
Study Highlights Lifelong Benefits of Statin Therapy

September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...

Home September 06, 2022
Home
Smokers have weaker hearts than non-smokers, according to research
News | Stroke
Smoking is Even More Damaging to the Heart Than Previously Thought

September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...

Home September 06, 2022
Home
Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.
News | Stroke
Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

Home September 06, 2022
Home
BOX trial presented in a Hot Line Session at ESC Congress 2022
News | Sudden Cardiac Arrest
Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

Home September 02, 2022
Home
DELIVER trial presented in a Hot Line Session at ESC Congress 2022
News | Heart Failure
Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

Home September 02, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now